Christine Posted October 15, 2007 Share Posted October 15, 2007 Silicon Valley / San Jose Business Journal Telik Inc. said Monday a partial hold on clinical trials for its cancer drug was lifted by the U.S. Food and Drug Administration. The Palo Alto-based biopharm (NASDAQ:TELK) said it was asked in June to temporarily halt trials for Telcyta, designed to treat ovarian and lung cancer. The company said the FDA had some safety concerns over the drug. Telik said that after a complete review of data, regulators permitted clinical development to resume on Telcyta. Quote Link to comment Share on other sites More sharing options...
RandyW Posted October 15, 2007 Share Posted October 15, 2007 thanks!!! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.